Radius Health, Inc. (RDUS) [Rocket]

Overview

Radius Health, Inc. (RDUS)

Add to portfolio

1m \| 3m \| 6m \| 1y \| 2y \| 5y \| 10y

Recent News + Filings (All items)

Date Filed	Type	Description
08/30/2022	SC 13D/A	BB BIOTECH AG reports a 0% stake in Radius Health, Inc.
08/30/2022	4	BIOTECH TARGET N V (10% Owner) has filed a Form 4 on Radius Health, Inc.
08/26/2022	SC 13D/A	Velan Capital Investment Management LP reports a 0% stake in Radius Health, Inc.
08/25/2022	15-12G	Form 15-12G - Securities registration termination [Section 12(g)]:
08/17/2022	SC 13G	Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
08/15/2022	4	Lisa Susan Vissers (Director) has filed a Form 4 on Radius Health, Inc.
08/15/2022	4	SANDERS MACHELLE (Director) has filed a Form 4 on Radius Health, Inc.

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Dec-31-21	Dec-31-20	Dec-31-19	Dec-31-18	Dec-31-17	Dec-31-16	Dec-31-15	Dec-31-14
Revenues	230.0	238.6	173.3	99.2	21.2	0.0	0.0	0.0
Revenue growth	-3.6%	37.7%	74.6%	368.6%
Cost of goods sold	0.8	0.8	0.8	0.8	0.4	0.0	0.0	0.0
Gross profit	229.2	237.8	172.5	98.4	20.8	0.0	0.0	0.0
Gross margin	99.7%	99.7%	99.5%	99.2%	98.1%
Selling, general and administrative	130.5	144.2	152.7
Research and development	134.6	159.7	116.8	99.9	83.1	107.4	68.3	45.7
General and administrative				184.2	186.7	77.5	30.8	13.7
EBITA	-53.5	-81.6	-111.4	-203.3	-249.0	-184.9	-99.1	-59.4
EBITA margin	-23.3%	-34.2%	-64.3%	-204.8%	-1175.5%
Amortization of intangibles	0.8	0.8	0.8	0.8
EBIT	-54.3	-82.4	-112.2	-204.1	-249.0	-184.9	-99.1	-59.4
EBIT margin	-23.6%	-34.5%	-64.8%	-205.6%	-1175.5%
Pre-tax income	-70.2	-109.2	-133.0	-221.3	-254.2	-182.8	-101.5	-62.5
Income taxes	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
Tax rate	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Net income	-70.2	-109.2	-133.0	-221.3	-254.2	-182.8	-101.5	-62.5
Net margin	-30.5%	-45.8%	-76.7%	-223.0%	-1200.4%

Diluted EPS	($1.49)	($2.35)	($2.89)	($4.88)	($5.80)	($4.24)	($2.56)	($3.53)
Shares outstanding (diluted)	47.2	46.5	46.0	45.4	43.8	43.1	39.6	17.7

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.